IUCC 2024 Sheds Light On AI Therapy Methods, Boosts Learning, Research With VR And AR

The fourth edition of the Interdisciplinary Urology Care Consortium (IUCC) 2024 commenced today and will run until 26 May 2024 at the Fairmont Bab Al Bahr in Abu Dhabi. The event features leading international doctors and lecturers under the theme "Transcending Therapies, Driving Technologies". The focus is on AI's role in diagnostic and therapeutic modalities across urology and other specialties.

Dr. Abdulqadir Al-Zarooni, President of the Emirates Urology Society (EUS) and IUCC Co-Chair, stated, "IUCC serves as a vital space for the exchange of knowledge among healthcare experts, uniting various medical disciplines with the shared objective of advancing urological patient care." He emphasised the importance of collaboration to ensure optimal healthcare standards.

The IUCC 2024 offers a platform where experts from various medical disciplines convene to communicate, share experiences, and stay updated on the latest developments. The forum is expected to draw over 800 participants from 20 countries and features more than 76 specialised speakers, including renowned doctors from diverse fields.

The event's agenda comprises eight scientific sessions featuring presentations, panel discussions, and seven workshops. These sessions showcase advancements in treating microscopic hematuria, laser urethrotomy, genital skin lesions, and various case discussions ranging from kidney stone treatment to bladder syndromes.

Topics include robotic surgeries, UTI treatment during pregnancy, recent developments in erectile dysfunction treatment, genetic testing in male infertility, and an evolutionary approach to prostate cancer management. The focus is on fostering a comprehensive approach to urinary care and encouraging research and publication in this field.

Given the growing importance of AI in diagnosis and treatment, the event prioritises this approach. Dr. Yasser Farahat, Chairman of the Arab School of Urology and IUCC Co-Chair, stated that this year's conference emphasises the utilisation of artificial intelligence in diagnosis and treatment. The event aims to delve into the latest scientific advancements in this domain.

Throughout IUCC 2024, multiple sessions and workshops will explore advancements in AI therapy tools and methodologies. Dr. Farahat highlighted that gathering esteemed urology experts worldwide aims to enhance treatment outcomes for patients through novel techniques.

Encouraging Research and Innovation

IUCC is dedicated to inspiring young urologists, fellows, and residents to actively pursue research and publication endeavours. A stimulating competition allows participants to submit their work for evaluation and recognition. This initiative encourages excellence and fosters a culture of innovation within the urology community.

Prof. Mohsen Elmekresh, Consultant and Head of Urology and Men’s Health at Mediclinic Middle East and IUCC Scientific Chair, noted that the annual forum showcases top treatment options from leading doctors worldwide. It provides a platform to discuss the latest scientific advancements, especially regarding AI's use in medicine.

Accreditation and Exhibition

Participants at IUCC 2024 can avail up to 14 CME credits accredited by Dubai Health Authority (DHA). The event is complemented by an exhibition showcasing advanced technologies and products from top urology companies. Participants can engage with exhibitors to gain insights into the latest technologies utilised in the field.

The fourth edition of IUCC is organised by the Arab Association of Urology and Arab School of Urology. It is supported by the Emirates Oncology Society, Dubai Health Authority, Abu Dhabi Department of Culture and Tourism, with INDEX Conferences and Exhibitions serving as the conference secretariat.

With inputs from WAM